Oncology

Oncology continues to dominate the drug development pipeline, reflecting both scientific opportunity and unmet clinical need. Rapid advances in precision medicine, immunotherapy, diagnostics, and cell and gene therapies are redefining outcomes in oncology—while the complexity and speed of innovation make ongoing education for clinicians and stakeholders more critical than ever.